金沙集团1862cc(股份)有限公司-baidu百科

2025-08-26

Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...

查看详情

06-192023

Bio-Thera Solutions Expands Partnership with Biomm in Brazil with Addition of BAT2206, a Stelara® Biosimilar

GUANGZHOU, China ---(Businesswire)--- Bio-TheraSolutions, Ltd (688177:SH), a commercial-stage biopharmaceutical companyd...
04-142023

Bio-Thera Solutions Announces BAT1006 Poster Presentations at the 2023 AACR Annual Meeting

GUANGZHOU, CHINA, April 14, 2023 – Bio-TheraSolutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, tod...
03-132023

Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8007, an Antibody-Drug Conjugate Targeting Nectin-4 for the Treatment of Advanced Solid Tumors

Guangzhou, China --(BUSINESSWIRE)-- Bio-TheraSolutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, to...